Regeneron Pharmaceuticals (REGN) Tax Rate Growth (1y) (2012 - 2026)

Regeneron Pharmaceuticals (REGN) Tax Rate Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,440.76 Bn 66,440.47 Bn -
2 Nanobiotix 1,909.20 Bn 1,909.14 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 468.28 Bn 463.49 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.49 Bn 115.24 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.26 Bn 61.51 Bn 3.31 Bn
7 Belite Bio 62.88 Bn 62.88 Bn -
8 Argenx Se 55.67 Bn 50.48 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.37 Bn 34.36 Bn 959.66 Mn
10 Revolution Medicines 37.28 Bn 37.28 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 187.00
Dec 31, 2025 1,486.00
Sep 30, 2025 699.00
Jun 30, 2025 -366.00
Mar 31, 2025 1,368.00
Dec 31, 2024 526.00
Sep 30, 2024 94.00
Jun 30, 2024 145.00
Mar 31, 2024 -773.00
Dec 31, 2023 -1,068.00
Sep 30, 2023 -358.00
Jun 30, 2023 -96.00
Mar 31, 2023 -357.00
Dec 31, 2022 -133.00
Sep 30, 2022 271.00
Jun 30, 2022 -589.00
Mar 31, 2022 -274.00
Dec 31, 2021 480.00
Sep 30, 2021 -550.00
Jun 30, 2021 1,507.00